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In  response  to  an  appropriate  stimulus  such  as  phagocytosis  of  an  opsonized 
particle,  macrophages reduce oxygen, first  to superoxide anion  (O2-), 1 and  then  to 
hydrogen  peroxide  (H202)  (1,  2).  These metabolites of oxygen are involved in  the 
killing  of phagocytosed  microorganisms  (3).  More  recently,  H202  has  also  been 
implicated  in  macrophage killing  of lymphocyte tumor  lines  (4,  5).  Macrophages 
obtained from the peritoneal cavity of mice infected with Bacille Calmette-Gugrin  (BCG) 
or injected intraperitoneally with bacterial lipopolysaccharide (LPS) display a greatly 
enhanced ability to generate 02- in response to stimulation by opsonized zymosan or 
the membrane-reactive agent phorbol myristate acetate  (PMA)  (6).  Such  activated 
macrophages also  exhibit  enhanced  H202  release  (2).  These observations correlate 
with studies showing that activated macrophages are better able to kill microorganisms 
(7, 8) and tumor cells (9,  10). 
Treatment  of macrophages  in  vitro with  LPS  has  been  shown  to  enhance  their 
ability to kill tumor cells (11-14),  and to increase their secretion of collagenase (15) 
and  other  hydrolytic  enzymes  (16).  N-Acetylmuramyl-L-alanyl-D-isoglutamine, or 
muramyl dipeptide (MDP), also enhances macrophage tumor cell killing in vitro (17). 
This segment of bacterial cell wall peptidoglycan is the minimal fragment that retains 
adjuvant properties  (18).  This same material has been shown  to cause macrophage 
migration  inhibition  when  incubated  with  mononuclear  cells  (19,  20),  to  induce 
granuloma formation in vivo (21), and to confer resistance to death by infection with 
Klebsiella pneumoniae  in  mice (22).  Macrophages exposed to MDP  in  vitro produced 
increased amounts of collagenase, prostaglandin, and a fibroblast proliferation factor 
(23).  We  report  here  that  direct  contact  of cultured  peritoneal  macrophages with 
MDP or LPS primes the cells to respond with increased 02- after stimulation  with 
PMA or opsonized zymosan. 
Materials and Methods 
Chemicals. PMA was obtained from Consolidated Midland Corp., Brewster,  N. Y.; a stock 
solution  of 2 mg/ml in dimethylsulfoxide (DMSO) was stored at -70°C.  1-10/tl of this stock 
* Supported by National Institutes of Health grants AI-14148 and DE-04871. 
1Abbreviations used in  this paper: BCG, Bacille Calmette-Gu~rin; DMEM, Dulbecco's modified Eagle's 
medium; DMSO, dimethylsulfoxide; FCS, fetal calf serum; HBSS, Hanks' balanced salt solution; LAF, 
lymphocyte-activating factor; LPS, bacterial lipopolysaccharide; MDP, N-acetylmuramyl-L-alanyl-D-iso- 
glutamine (or muramyl dipeptide); O2-, superoxide anion; PMA, pborbol myristate acetate; SRBC, sheep 
erythrocyte(s). 
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solution was added directly to the O2- assay mixture just before use. An equivalent volume of 
DMSO had no effect. 
The LPS used in this study was a gift from Dr. Floyd McIntire of the University of Colorado 
School of Dentistry,  Denver, Colo. The preparation  was phenol-extracted  from Escherichia coil 
K235,  treated with detergent, and  purified by gel filtration  (24).  This LPS was free from the 
lipid A-associated endotoxic protein. Examination of the UV spectrum of the LPS showed no 
detectable  ubiquinone contamination  (<1  part  per  1,000)  (25).  Less than  0.1  ng of this LPS 
was detectable by the limulus amebocyte lysate assay. Limulus lysate (E-toxate) was obtained 
from Sigma Chemical Co., St. Louis, Mo., and was used according to the instructions in Sigma 
Technical Bulletin No. 210. A butanol-extracted LPS that contained lipid A-associated protein 
(26)  was  a  gift  from  Dr.  Sally  Betz  of the  Institut  de  Biochimie,  Universit6  de  Lausanne, 
Epalinges, Switzerland. 
MDP was purchased  from the Pasteur  Institute,  Paris,  France.  The D-D isomer was a  gift 
from  Dr.  Louis  Chedid  of the  Pasteur  Institute.  The  L-L isomer was  a  gift  from  Dr.  Shozo 
Kotani  of the Osaka  University Dental  School, Osaka, Japan.  MDP and  its isomers,  which 
were synthesized chemically, were negative for LPS by the limulus assay; stock solutions at  10 
/~g/ml (20/~M) were tested. 
Mice. Swiss-Webster mice were either bred at National Jewish Hospital or purchased  from 
Charles  River Breeding  Laboratories,  Wilmington,  Mass.,  or  from  Bio-Lab Corp.,  St.  Paul, 
Minn.  Nude  mice were purchased  from Timco Breeding Laboratories,  Houston,  Tex. C3H/ 
HeJ and C3Heb/FeJ mice were purchased from The Jackson Laboratories, Bar Harbor, Maine. 
All mice were 1- to 2-mo-old females. 
Macrophage Harvesting and Cultivation. Peritoneal cells were harvested as previously described 
(6), washed, and allowed to adhere for 2 h to 35-ram diameter tissue culture dishes in Dulbecco's 
modified  Eagle's medium  (DMEM)  that  contained  penicillin, streptomycin,  and  20%  heat- 
inactivated fetal calf serum (FCS) (6). Nonadherent cells were washed away with fresh medium. 
After the 2-h adherence, 96-98% of adherent cells phagocytosed antibody-coated sheep eryth- 
rocytes  (SRBC).  Erythrocytes  were  treated  with  a  1:300  dilution  of rabbit  anti-SRBC  IgG, 
then washed  three times with Hanks' balanced  salt solution  (HBSS).  Erythrocytes,  1 ml of a 
2.5% cell suspension  in HBSS, were added to the macrophage cultures for 60 min at 37°C in 
5%  CO2.  The  cultures  were  washed  vigorously  three  times  with  HBSS,  then  treated  with 
distilled water for 30 s to lyse external erythrocytes, followed by a further washing with HBSS. 
The macrophage cultures were then examined by phase contrast microscopy, and the percentage 
of cells that  had  phagocytosed  erythrocytes  was  determined  by  two  independent  observers. 
Many of the nonphagocytosing cells appeared to be of the monocyte-macrophage line, because 
they bore small pseudopods.  Approximately 2% of the adherent  cells appeared  to be lympho- 
cytes, perhaps  adherent  B  cells, as previously described  (27).  After the initial  2-h adherence, 
cells were incubated overnight in DMEM  (with antibiotics but without FCS) and with either 
LPS, MDP, or saline as control. The number of granulocytes that  survived overnight culture, 
and which could theoretically interfere in the 02- assay, was <2%  (6). 
All results reported here have been confirmed with solutions that were LPS-free, as tested by 
the  limulus  assay.  The  FCS  routinely  used  for  adherence  contained  LPS.  However,  results 
identical to those reported were obtained with cells cultured in 1% heat-inactivated autologous 
mouse serum,  which was negative for LPS by the limulus assay.  Mouse serum was not  used 
routinely because it permitted an increased percentage of lymphocytes to adhere. The effect of 
LPS  or  MDP  reported  here  could  be  achieved  in  the  presence  of FCS,  but  FCS  was  not 
routinely present during the LPS or MDP treatment, because it tended to elevate to a variable 
degree the 02- response of control cells. This effect may have been a result of LPS contamination 
of the serum or to factors inherent in the serum itself. 
02- Assay. After overnight exposure to LPS or MDP, the cells were washed twice with HBSS, 
then  assayed  for 02-  production  in  response  to stimulation  for 60  min  by 0.5 ~g/ml  PMA, 
using superoxide dismutase-inhibitable reduction of ferricytochrome c, as previously described 
(6).  Results  are presented  as  nanomoles of 02-  released  in  60  minutes  per milligram of cell 
protein.  Because 02- generated by cells without PMA treatment was <2 nmol/60 min per mg 
protein, individual assays in the absence of PMA were not routinely performed. 
Protein Determination. Protein  was  determined  by  the  Lowry  method,  with  bovine  serum 
albumin as standard.  After the O2- assay, culture dishes were washed three times with HBSS, M. J.  PABST AND  R.  B. JOIINSTON, JR.  103 
copper-tartrate reagent  was  added  directly to  the culture dishes,  and the remainder of ~he 
procedure was performed directly in the dishes. 
J774.1 Cell Line. J774.1  cells were obtained originally from Dr. Peter Ralph, Sloan-Kettering 
Institute, Rye, N. Y.  (6). The cells were grown in suspension in 10-cm microbiological plastic 
Petri dishes (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.)  in DMEM that 
contained 20~  heat-inactivated FCS and antibiotics. Cells  did not adhere, or adhered  very 
weakly,  to the plastic dishes that had not been treated for tissue culture by the manufacturer. 
Cultures were established by adding five drops of cell suspension from a previous culture to 15 
ml of the medium, followed by incubation at 37°C in 95% air  5~7~; CO2 for 5 d. The cells were 
harvested, washed, and resuspended in fresh  DMEM with FCS and antibiotics at  2.5  X  I0  ~ 
cells/ml. 1 ml of the cell suspension was added to each 35-ram dish and allowed to adhere for 
2 h at  37°C in 95% air-5% CO2. Essentially all cells adhered. After adherence, the cells were 
washed,  then incubated in 2 ml of DMEM without serum, and with either saline, LPS,  or 
MDP for 4 h. The 4-h time period was selected  because the cell line did not tolerate long-term 
culture in the absence of serum, nor did the cells respond with increased PMA-stimulated Oz 
generation after incubation with MDP or LPS in the presence of 20~  heat-inactivated FCS, 
1%  heat-inactivated mouse serum, or 20% horse  serum. The dishes  were washed  twice  with 
HBSS,  then assayed  for  02-  production in response to  I /~g/ml  PMA.  Because  of the  low 
amounts of 02- produced by J774.1  cells, results with each concentration of MDP and LPS 
were compared with those obtained with the same reaction mixture in the absence of PMA. 
Results 
Effect of LPS and MDP on Cultured Macrophages.  Resident mouse peritoneal macro- 
phages which were cultured overnight in the presence of MDP (Fig.  1 b) consistently 
showed  markedly enhanced pseudopod  formation compared with control cells cul- 
tured in medium alone (Fig.  1 a). Cells treated with LPS (Fig.  1 c) were characterized 
by long, thin pseudopodia, which  were  not  found in control or  MDP-treated cells 
under these conditions. 
The enhanced spreading produced by overnight incubation with LPS and MDP is 
summarized for a  typical cell preparation in Table I. This effect correlated with an 
increased O2--generating capacity  of the  treated  cells  (Table I).  When stimulated 
with PMA, cells treated with LPS produced almost seven times more Oz- than did 
cells preincubated with saline, and cells treated with MDP produced twice as much 
02- as did control cells. In contrast, cells treated with stereoisomers of MDP, which 
have been shown to be inactive as  adjuvants (18,  28), were not primed to  produce 
more 02-. 
Exposure  to  MDP  or  LPS  did  not,  in  itself,  cause  the  production  of 02-  by 
macrophages.  Macrophages  treated  only with  LPS  or MDP but  not stimulated by 
PMA produced <2 nmol Oz-/mg (n =  6).  Opsonized zymosan (13 #g/ml) was also 
effective as a  stimulus. However,  zymosan elicits more 02-  from  resident  (control) 
macrophages  than  does  PMA  (6),  and  the  differences between control  (176  +  12 
nmol/mg protein, mean +  SEM, n  =  4)  and MDP- or LPS-treated cells (228  +  12 
or 320 +  10, respectively, n =  4)  were less than the differences observed with PMA. 
MDP and LPS were effective at enhancing  O2--generating  capacity ofmacrophages 
over a  wide range of concentrations, as shown  in  Fig.  2.  Increased O2--generating 
capacity was achieved after exposure to submicrogram quantities of either material. 
LPS  at  0.01-1  #g/ml appeared  to  be optimal;  LPS  at  10/~g/ml was  less effective, 
perhaps  a  result  of  toxic  effects  on  the  cells  (29).  MDP  was  most  effective  at 
concentrations >0.5  /~g/ml,  although  activity persisted  down  to  0.05  /~g/ml.  The 
inactive stereoisomers of MDP had no effect at 0.05, 0.5, or 5/~g/ml. 104  ENHANCEMENT  OF  MACROPHAGE  SUPEROXIDE  RELEASE 
Fic,  1.  Phase contrast micrographs of resident mouse peritoneal macrophages. Cells were allowed 
to adhere to tissue culture dishes for 2 h in DMEM with 20% heat-inactivated FCS and antibiotics, 
then washed and cultured overnight in DMEM without serum. Cultures were washed again before 
photography.  (a)  Control  macrophages  cultured  overnight  in  medium  alone.  (b)  Macrophages 
incubated overnight with 1/~M (0.5 #g/ml) MDP. (c) Macrophages incubated overnight with 1/Lg/ 
ml LPS. 
The  time-course  of the  effect  of LPS  and  MDP  is  shown  in  Fig.  3.  A  significant 
effect  of LPS  was  observed  within  30  min.  In  contrast,  the  first  effect  of MDP  was 
noted at 4  h. The effect of LPS was greater than  that of MDP  at all time points; with 
continuous  exposure,  the  response  to  MDP  declined  more  rapidly  than  did  the M. J.  PABST  AND  R.  B. JOHNSTON, J~.  105 
TABLE  I 
Effect of Priming with MDP or LPS on Spreading and on PMA-stimulated 02- Release by Mouse 
Peritoneal Macrophages 
Treatment*  PMA-stimulated 02- release  S  Spreading§ 
nmol/mg protein  % 
Control (saline)  67 ±  12 (6)  25 
LPS (1 #g/ml)  450 ±  53 (6)  86 
MDP (l/.tM)  140 +  10 (6)  37 
MDP, L-L stereoisomer  (1 p,M)  71  +_  13 (3)  -- 
MDP, D-D stereoisomer  (1 #M)  78 +  15 (3)  -- 
* After adherence for 2 h to culture dishes in DMEM-20%  FCS with antibiotics, resident mouse macro- 
phages were preincubated overnight in medium alone or medium with MDP, MDP analogue, or LPS. 
The cells were washed twice before being assayed  for 02- release or examined for spreading. 1 #M of 
MDP is -  0.5 btg/ml. 
$ 02- was quantitated by its capacity to reduce ferricytochrome c, as described in Methods. Cells were 
stimulated with 0.5/tg/ml PMA for 60 min. The values shown represent mean ±  SEM. The number of 
experiments, done in duplicate or triplicate, is given in parentheses. 
§ Culture dishes were coded, and ~200 cells were counted with phase microscopy on each of two culture 
dishes by two independent observers. The values shown represent the mean percentage of cells that show 
definite pseudopod formation. Although pseudopod formation was not counted in the case of the L-L and 
D-D analogues,  these cells did not differ in appearance from control cells. 
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FIC.  2.  Effect of concentration of MDP or LPS on enhancement of the O2--generating capacity of 
resident macrophages cultured overnight in medium without serum. Values shown represent the 
mean 02- produced in response to stimulation with 0.5/xg/ml of PMA after priming with LPS or 
MDP (six replicates  each).  The standard error of all  points was  15 or less. The 02-  response of 
untreated control cultures was 84 ±  7 (SEM, n =  6).  MDP from three different sources  (Pasteur 
Institute, Dr. Kotani, and Calbiochem-Behring  Corp., American Hoechst Corp., San Diego, Cali£) 
was used (two replicates  from each source, yielding n =  6); the three sources of MDP gave almost 
identical results at all concentrations (SEM <15). 
response to LPS. After 4 d, all cells appeared healthy under phase contrast microscopy, 
and the 02-  response of the control cells was undiminished. 
Role of Lymphocytes  in the Response of Macrophages  to LPS and MDP.  We explored the 
question of whether, in the preceding experiments, MDP  and LPS had acted directly 106 
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Fro.  3.  Effect of the  time  of exposure to  [,PS or  MDP  on  the  O2--generating  capacity  of 
macrophages. All cultures were started after an initial 2-h adherence (time 0). Results with cultures 
exposed to  LPS or  MDP  for periods of time  up  to  24  h  were compared  with  those of control 
(untreated) dishes cultured for 24 h in DMEM alone. Cultures exposed to LPS or MDP for 48, 72, 
or 96 h were compared with control cells incubated for the corresponding period of time. Means for 
duplicate cultures are plotted. The bars represent 1 SEM. Results are representative of those of four 
experiments. The insert (B) is an expansion of Fig. 3A at earlier time points. 
on  the  macrophages  themselves,  or  had  interacted  with  adherent  lymphocytes  to 
cause the production of lymphokines, which, in  turn,  had  primed  the macrophages. 
In  the  experiments  represented  in  Table  II,  cells  that  were  nonadherent  after  the 
initial  2-h  incubation  were  removed and  washed,  then  re-added  to  one-half of the 
macrophage  cultures.  Thus,  the  cultures  to  which  nonadherent  cells were  re-added 
contained  between  one  and  two  times  the  number  of nonadherent  cells  that  were 
originally present  in  the  peritoneal  lavage  (1-2  ×  106  nonadherent  cells  per  dish). 
The cells were then  incubated  overnight with  MDP  and  LPS.  On  the  next  day  the 
cultures were washed and assayed for 02- production. The presence of the nonadher- 
ent  cells  during  the  LPS  and  MDP  treatment  produced  an  enhancement  of 02- 
production  in  both  control  and  MDP-treated  cells.  However,  the  presence  of the 
nonadherent cells did not enhance the relative response of the macrophages to either 
LPS or MDP. 
Macrophages maintained in culture for 24 or 48 h, to further reduce the possibility 
of lymphocyte contamination, responded as well to subsequent  printing by LPS and 
MDP  as  did  cells whose priming began  after the  initial 2-h  adherence  (four experi- 
ments,  data  not shown).  Addition of freshly harvested  nonadherent  cells at  10 4,  105, 
or  106 cells per dish had no significant effect on the priming response of macrophages 
cultured for 24 or 48 h  before priming. 
To evaluate further whether macrophages respond directly to LPS and MDP, cells 
were prepared from nude mice (Swiss-Webster nu/nu), which lack mature T  lympho- M. J.  PABST  AND R.  B. JOHNSTON, JR.  107 
TABLE II 
Evaluation of the Rote of Lymphocytes b~ the Macrophage Response to MDP and LPS: Effect of the 
Addition of the Nonadherent Cell Population 
Treatment 
PMA-stimulated  02- release* 
Macrophages alone  Macrophages + nonad- 
herent cells 
nmo~mgpmtem 
Control (saline)  74 ±  I0  146 +-  5 
LPS (1/.tg/ml)  437 ±  13  439 ±  16 
MDP(I#M)  140±  9  202± 10 
MDP, n-D isomer (1 ~tM)  82 --  4  153 +_ 11 
* Results are means + SEM for triplicate assays. Dishes that contained nonadherent  cells alone produced 
no detectable 02-. These results are representative of those obtained in four experiments. 
TABLE III 
Priming of Macrophages  from Nude Mice by MDP and LPS 
Treatment  PMA-stimulated  02- release* 
nmol/mg protein 
Control (saline)  78 +  17 
LPS (1 #g/ml)  340 +  16 
MDP (I #M)  145 ±  11 
MDP, o-n isomer (I #M)  83 +  11 
* Results are means + SEM of two experiments done in duplicate. 
cytes.  As  shown  in  Table  Ill,  peritoneal  macrophages  from  nude  mice  responded 
normally to  MDP  and  LPS.  Thus,  mature  T-cell  function  does  not  appear  to  be 
essential  for  the  response  of macrophages  to  either  LPS  or  MDP  in  this  in  vitro 
system. 
The effect of LPS and MDP was also tested on the C3H/HeJ  strain of mice, which 
has been reported to have both B  lymphocytes and macrophages that are defective in 
their  response  to  LPS  with  respect  to  B-cell mitogenesis,  macrophage  tumor  lysis, 
LPS-induced lethality, and  production  of prostaglandin and  lymphocyte-activating 
factor  by  macrophages  (30-37).  As  shown  in  Fig.  4,  at  all  concentrations  of LPS 
tested,  macrophages  from  the  C3H/HeJ  strain  gave  a  definite,  but  only  partial, 
response to phenol-extracted LPS.  In other systems, cells from C3H/HeJ  mice have 
responded  much  better to butanol-extracted  LPS  (34,  36),  which  contains lipid A- 
associated protein  (26),  than  to  phenol-extracted  LPS.  Butanol-extracted  LPS  also 
primed HeJ macrophages to produce more 02- than did phenol-extracted LPS (Fig. 
4). With macrophages from a  closely related normal strain of mice, C3Heb/FeJ,  the 
two  forms of LPS had  equal  priming capacity at  all concentrations  tested  from  0.1 
ng/ml  to  10 #g/ml;  the results being similar to those observed with  Swiss-Webster 
cells in Fig. 2. 
Macrophages from C3H/HeJ  mice responded normally to MDP  (Table IV). The 
levels of 02- released after PMA stimulation were equivalent to those achieved with 
MDP-primed Swiss-Webster or C3H/FeJ  macrophages. 
When nonadherent  cells from C3Heb/FeJ  cultures were added to cultured C3H/ 
HeJ macrophages, no appreciable change in response to either purified LPS or MDP 108  ENHANCEMENT OF  MACROPHAGE SUPEROXIDE  RELEASE 
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FIG. 4.  Priming of C3H/HeJ  macrophages by phenol-extracted LPS compared with butanol- 
extracted LPS. Values shown are means of four replicates. Standard error of all points was <15. 02- 
release of control (untreated) cultures was  78  +  7 SEM  (four replicates). This experiment is 
representative of two performed. 
TABLE  IV 
Priming of macrophages from C3H/HeJ and C3Heb/FeJ Mice by MDP 
Treatment 
PMA-stimulated 02- Release* 
HeJ  FeJ 
nmol/mg protein 
Control (saline)  72 ±  7  68 ±  16 
MDP(0.01btM)  71 +  4  82+-  3 
MDP(0.1pM)  80+  1  96+  4 
MDP (1.0/~M)  272 ± 25  191 ±  1 
*  Results  are  means  +  SEM  for  duplicate  assays.  Results  are  representative  of those  obtained  in  three 
experiments. 
was observed (Table V), which indicates that normal lymphocytes from the FeJ strain 
could  not  repair  the  weak  HeJ  macrophage  response  to  purified  LPS.  (The  FeJ 
nonadherent cells had  a  slight stimulatory effect  compared with  HeJ  nonadherent 
cells, but this was the same for both LPS-treated and control cells.) Nor did the HeJ 
nonadherent cells appear to significantly suppress the response of FeJ macrophages to 
LPS.  These  results  suggest  that  MDP  and  LPS  act  directly  on  the  macrophages 
themselves. 
To further evaluate the role of lymphocytes, the effect of MDP and LPS was tested 
on the macrophage-like cell line, J774.1. For technical reasons (see Methods), this cell 
line was treated with LPS or MDP for only 4 h, the minimal time required to observe 
a  response to MDP by normal peritoneal macrophages (Fig. 3). The 02- response of 
these cells was ~ 10% that of peritoneal cells, but the cells remained >98% viable by M.  J.  PABST  AND  R.  B.  JOHNSTON, JR.  109 
TABLE  V 
Effect of HeJ and FeJ Nonadherent Cells on the Response of HeJ and FeJ macrophages to MDP and LPS 
Macrophage  Nonadherent cell 
PMA-stimulated 02- release* 
Control (saline)  LPS (1 #g/ml)  MDP (1 #M) 
nmol/mg protein 
HeJ  HeJ  17 4- 7  107 4-  1  114 4- 28 
HeJ  FeJ  35 4- 6  139 4- 4  116 4- 8 
FeJ  HeJ  145 4- 7  306 4- 21  255 4- 8 
FeJ  FeJ  176 4- 26  316 4-  13  283 4-  14 
* Results are means +  SEM of duplicate assays. Dishes that contained nonadherent cells alone produced 
no detectable 02-. These results are representative of those obtained in three experiments. 
TABLE  VI 
Priming ofJ774.1  Macrophage-like Cell Line by LPS and MDP 
Treatment  PMA-stimulated Oz- release* 
nmol/mg protein 
Control (saline)  6.7 4- 0.7 
LPS (1 #g/ml)  13.3 +  0.8~ 
MDP (1 #M)  10.0 +  0.9:[: 
MDP, D-D isomer (1 #M)  6.2  4-  1.4 
* Values are means +  SEM for seven to nine cultures incubated for 4 h in the presence of saline (control) 
or the substance shown, then stimulated by incubation with PMA for 60 rain. 
:~ Significantly different from control (P <  0.002,  Student's one-tailed t test for independent variables). 
a trypan blue exclusion test. As shown in Table VI, a significant enhancement of 02-- 
production by both MDP and LPS was observed. 
Discussion 
In vitro treatment of peritoneal  macrophages with LPS or MDP, compared with 
preincubation  in  medium  alone,  results  in  the  macrophages  becoming primed  to 
release several times more 02- after stimulation by PMA or opsonized zymosan. This 
priming process occurs within a  matter of hours after exposure to LPS or MDP. It is 
concentration dependent and associated with other manifestations of activation such 
as increased pseudopod formation. 
Because peritoneal macrophages become primed after exposure to as little as 0.1 
ng/ml of LPS, the presence of LPS in reagents becomes a serious problem. In the case 
of MDP, which was synthesized chemically, priming was not a result of contamination 
by LPS,  because MDP was negative in  the limulus assay (a  10-#g/ml  test solution 
had <0.1  ng/ml of LPS);  MDP from three independent  laboratories gave superim- 
posable dose-response curves (Fig. 2); and analogues of MDP synthesized in the same 
laboratories  did  not  prime  macrophages.  However,  the  presence  of LPS  must  be 
considered in testing the effects on macrophages of commercial reagents and products 
isolated from natural sources (33). 
It is difficult to prove that adherent lymphocytes are not essential for the priming 
response,  but  the  weight  of evidence  presented  here  suggests  that  MDP  and  LPS 
achieve their effect through  direct  interaction  with macrophages. Greater than 95% 110  ENHANCEMENT OF MACROPHAGE SUPEROXIDE RELEASE 
of the cells in preparations routinely used were capable of phagocytosing antibody- 
coated erythrocytes. Deliberate addition of nonadherent cells made no difference to 
the  response  of macrophages  to  LPS  or  MDP,  although  it  could  be  argued  that 
sufficient lymphocytes were already present to produce the maximal response. Mac- 
rophages from nude mice, which lack mature T  lymphocytes, responded normally to 
LPS and  MDP.  Macrophages from C3H/HeJ  mice were tested because cells from 
this strain have responded abnormally to LPS in several systems  (30-37). A  partial 
defect  in  response  to  LPS  was  exhibited  by  C3H/HeJ  macrophages;  the  defect 
remained regardless of whether C3H/HeJ or C3H/FeJ  (normal)  lymphocytes were 
present. This result indicated that LPS interacts directly with the macrophages. The 
observation  that  the  macrophage-like  cell  line  responds  to  LPS  and  MDP  also 
provides evidence that  these  compounds  directly affect macrophages.  Finally,  the 
onset of priming after 30-min or 4-h of exposure to LPS or MDP, respectively, is a 
more prompt  response than  that  expected from exposure to lymphokines  (13). This 
conclusion is further supported by data obtained in a tumor-cell killing system. With 
pure populations of cloned macrophages from bone marrow as effector cells, Weinberg 
et al.  (33)  showed that  LPS could increase cytotoxicity in the complete absence of 
lymphocytes. 
The partial response of C3H/HeJ macrophages to purified phenol-extracted LPS 
with respect to priming for O~- generation is interesting in view of reports that this 
type of LPS does not  stimulate  either the production of the macrophage product, 
lymphocyte-activating factor (LAF)  (36), or glucose utilization (37) by cultured He] 
macrophages. Addition of FeJ lymphocytes to the HeJ macrophages had no effect on 
LAF production (36) but did enhance glucose utilization (37).  Apparently, the need 
for lymphocyte involvement may vary depending upon the particular macrophage 
function being studied. The normal response of C3H/HeJ macrophages to MDP was 
not surprising, because MDP, unlike LPS, appears to have a normal adjuvant effect 
in C3H/HeJ mice (18). 
The normal response of macrophages from nude mice to priming by LPS and MDP 
may be a  phenomenon which contributes to the surprising ability of nude  (nu/nu) 
mice to survive a challenge infection that is lethal to normal (nu/+)  littermates (38- 
40).  Although  the  reason  for the enhanced survival of nude  mice remains  unclear 
(40), one hypothesis is that, in the absence of T-cell-mediated immunity, nude mouse 
macrophages are exposed to increased amounts of bacterial products, and are thereby 
chronically activated. These activated macrophages then provide an increased level 
of nonspecific resistance to infectious challenge. 
In a normal intact animal, LPS would be expected to interact with B  (41)  and T 
cells (30), as well as with macrophages as shown here. MDP has also been shown to 
interact  with  both  B  and  T  cells  (42-44).  A  combination  of  direct  effects  on 
macrophages and indirect effects via lymphokines could raise the macrophages to a 
higher state of activation than  that  achieved by the  direct effect on  macrophages 
alone. Such a combined effect of LPS and lymphokines has been shown in vitro with 
a tumor lysis assay (32).  Nevertheless the in vitro priming to greater stimulated 02- 
response represents at least one step in the process of macrophage activation (32).  In 
fact, the degree of stimulation of O2--generating capacity achieved in vitro with LPS 
(from  67  to  450  nmol  O2-/mg)  is  equivalent  to  the  difference in  O2--generating 
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jected  to  LPS  or  BCG  activation  in  vivo  (from 49  to  590  nmol/mg for LPS;  493 
nmol/mg for BCG)  (6).  It remains  to be determined  whether  cells primed  in  vitro 
manifest greater microbicidal or tumoricidal activity, or whether further differentia- 
tion,  perhaps under the influence of lymphokines, is required  for efficiency of these 
critical functions. 
The complement system may play a role in macrophage activation by LPS in vivo. 
Although  cultured  macrophages  may  synthesize  components  of  the  complement 
system, experiments with  MDP suggest that complement activation is probably not 
a  requirement  for priming  in  vitro,  at  least  with  MDP.  We  found  that  MDP,  at 
concentrations  up to 50/~M,  did not  activate the alternative pathway in  serum, as 
tested  by a  sensitive kinetic hemolytic assay (45),  and activation of complement by 
the classical pathway would require antibody and C1, which should not be present in 
macrophage cultures. 
Although the in vitro priming effect of LPS and MDP may represent only one step 
or aspect  of the  process of macrophage activation  as  it  occurs  in  vivo, this  system 
should provide a useful tool. The addition of chemical effectors and inhibitors to cells 
undergoing  priming by LPS or MDP may reveal some of the mechanisms that  are 
involved in the process of macrophage activation. 
The  initial  product  of  the  respiratory  burst  that  characterizes  phagocytic  cells 
appears to be 02- (1).  Spontaneous dismutation of 02- leads to H2Oz formation, and 
ensuing molecular interactions generate hydroxyl radical and, perhaps, singlet oxygen 
(1).  These  toxic  metabolites  of oxygen  are  required  for  efficient  killing  of many 
microorganisms and, at least in some systems, for lysis of tumor cells (1, 3-5, 8). Our 
studies suggest that certain microbial products can interact directly with macrophages 
to accentuate their oxidative metabolic response to plasma membrane perturbation. 
Thus,  in  appropriate situations,  exposure of macrophages to LPS,  MDP,  or related 
fragments of microbial cell surface constituents could result in an increased capacity 
to kill infecting microorganisms. On the other hand, this same mechanism could also 
permit macrophages to mediate oxidative tissue injury. 
Summary 
After in vitro exposure to lipopolysaccharide (LPS) or muramyl dipeptide (MDP), 
cultured  resident  mouse peritoneal  macrophages were primed  to display enhanced 
generation of superoxide anion (02-) in response to stimulation by phorbol myristate 
acetate  (PMA)  or  opsonized  zymosan.  Priming  with  LPS  (1  #g/ml)  produced  a 
sevenfold  enhancement  of PMA-stimulated  02-  generation;  priming was  detected 
within  30 min and persisted for at  least 4  d.  Exposure to MDP  (1  /tM)  primed the 
macrophages to double their 02- release; the response was first observed after 4 h and 
persisted for at least 3 d. The priming response was not observed with stereoisomers 
of MDP, which are inactive as adjuvants. 
LPS and MDP appeared to work directly on the macrophages rather than indirectly 
by interacting with adherent  lymphocytes: (a) Addition of nonadherent  cell popula- 
tions that contained lymphocytes had no effect on the response. (b) The response was 
normal with cells from nude mice, which lack mature T  lymphocytes. (c) Macrophages 
from C3H/HeJ mice, whose B lymphocytes fail to respond to LPS, were weak in their 
response to priming by LPS; the addition of normal  (C3Heb/FeJ)  nonadherent  cells 112  ENHANCEMENT  OF MACROPHAGE  SUPEROXIDE RELEASE 
had  no effect  on  this  weak  response.  (d)  The  macrophage-like  cell  line J774.1  also 
showed enhanced O2--generating capacity after a  4-h exposure to LPS or MDP. 
The  O2--generating  capacity  of  macrophages  primed  with  LPS  in  vitro  was 
equivalent to that previously observed with cells elicited in vivo by injection of LPS 
or activated by infection with Bacille  Calmette-Gudrin.  The data suggest that  previous 
exposure  to bacterial  products could prime macrophages  to respond  with  increased 
production of toxic oxygen metabolites on contact with invading microorganisms or 
tumor cells. 
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